NASDAQ: RNXT - RenovoRx, Inc.

Yield per half year: +15.04%
Dividend yield: 0.00%
Sector: Healthcare

RenovoRx, Inc.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 48.77 -100% -3.25 -100%
P/S 0 33.77 -100%
P/BV -3.94 4.83 -181.71%
P/FCF 0 61 -100%
Ev/Ebitda -0.9355 -22.17 -95.78%
Ev/S 0 22.57 -100%
Ev/FCF -1.04 68.76 -101.51%
E/P 0 0.0178 -100%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 4.97 -100% 0 0%
ROE 341.07 9.61 3448.5%
ROA -697.95 0.3443 -202840.58%
ROIC 0 7.63 -100%
ROS 0 -25.17 -100%
ROCE 380.07 15.45 2360.05%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0 -3.68 -100% -0.8208 -100%
Nеt Debt/Ebitda 0.1029 -3.44 -102.99%
Debt/Ratio 0 0.1986 -100%
Debt/Equity 0 1.66 -100%
Debt/Net Income 0 10.32 -100%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.541 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2256 -100%
Average dividend growth 0 0.9598 -100%
Average percentage for 5 years 0 0.4928 -100%
Average percentage for payments 0 43.56 -100%
Difference from average difference in sector -0.541

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
0 -57.64 -100%
Growth impulse Ebitda in 5 years 199.89 -90.94 -319.8%
Growth impulse Net Income in 5 years 169.26 -97.8 -273.07%
Growth impulse FCF in 5 years 201.71 -108.72 -285.53%
Growth impulse EPS in 5 years 120.42 -142.05 -184.77%
IP Score
4.77/10

Similar companies

Alexion

Amgen

ABIOMED

Gilead Sciences

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription